Nov 14, 2023 / 04:30PM GMT
Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Okay everybody. Welcome back to the 2023 Stifel Healthcare Conference on the Life Sciences and Diagnostics track here, and I'm happy to have CEO, Thierry Bernard from QIAGEN with us. Thierry thanks for joining us.
Thierry Bernard - Qiagen N.V. - CEO, MD & Member of Management Board
Good morning. Thank you.
Questions and Answers:
Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior AnalystOur pleasure. Maybe a place to start, which I've been doing with some of our companies here is just sort of recap the last quarter, 5% CER growth for the nonbusiness this quarter was outside of 1 or 2 players, the highest in the core tools group, I think it's worth noting. Can you just maybe talk where the relative strength in the business is today on the non-COVID side?
Thierry Bernard - Qiagen N.V. - CEO, MD & Member of